Article
RAD52 variants influence NSCLC risk in the Chinese population in a high altitude area.
Therapeutic advances in respiratory disease - 1 Jan 2000
Li Miao, Chen Rong, Ji Baoyan, Fan Chunmei, Wang Guanying, Yue Chenli, Jin Guoquan
Abstract excerpt
BACKGROUND: Non-small cell lung cancer (NSCLC) accounts for approximately 80% of diagnosed lung cancer patients. RAD52 has been reported to be associated with the development of squamous cell lung carcinoma. In this study, we assessed the relationships of RAD52 genetic polymorphisms and NSCLC risk among the Chinese population at high altitude. METHODS: Eight single nucleotide polymorphisms (SNPs) of RAD52 were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
